Funding and support

The Editoral Base of the Cochrane Haemtological Group (CHMG)  is funded under the auspices of the German Federal Ministry of Education and Research (BMBF), Deutsche Krebshilfe e.V.  and in addition by the funding programme Köln Fortune from the medical faculty University of Cologne.

Currently following projects at the CHMG Editorial Base in Cologne are funded by the German Federal Ministry of Education and Research and the German Cancer Aid:

  • Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysis (BMBF grant application, No: 01KG1711)

  • Interim PET for prognosis in adults with Hodgkin lymphoma: a prognostic factor exemplar review (BMBF grant application, No: 01KG1709)

  • Bisphosphonates or RANK-ligand-inhibitors for patients with prostate cancer and bone metastases: A Cochrane systematic review and network meta-analysis (BMBF grant application, No: 01KG1702)

  • Update of the interdisciplinary evidence-based guideline for Hodgkin´s Lymphoma in Adults, diagnosis, treatment and follow-up (Funding provided by the German Cancer Aid)

  • Interdisciplinary evidence-based guideline for diagnosis, therapy and follow-up of adult follicular lymphoma patients (Funding provided by the German Cancer Aid)

  • Interdisciplinary evidence-based guideline for diagnosis, therapy and follow-up of multiple myeloma patients (Funding provided by the German Cancer Aid)